Case report: Sintilimab combined with anlotinib as neoadjuvant chemotherapy for metastatic bone tumor resection in patients with PSC

Overview of attention for article published in Frontiers in immunology, May 2024

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

Mentioned by

twitter: 1 X user

reddit: 1 Redditor

Readers on

mendeley: 1 Mendeley

Summary X Reddit

So far, Altmetric has seen 1 Reddit thread.

Frontiers | Case report: Sintilimab combined with anlotinib as neoadjuvant chemotherapy for metastatic bone tumor resection in patients with PSC

User WalkingHorse, in the LungCancerSupport subreddit, 17 May 2024

This page shows the most recent Reddit threads that mention this research output.

Click here to find out how to access more activity.